Thyroid disorders induced by immune checkpoint inhibitors therapy of malignant tumors

Thyroid disorders induced by immune checkpoint inhibitors therapy of malignant tumors

In the recent years, immune checkpoint inhibitors (ICPI) have been widely used for treatment of many malignant neoplasms. In the Russian Federation, several ICPIs have been approved and actively used, namely anti-CTLA-4 monoclonal antibody (ipilimumab), anti-PD-1 monoclonal antibodies (nivolumab, pe...

Full description

Bibliographic Details
Main Authors: Anastasiya A. Glibka, Natalya V. Mazurina, Ksenia A. Sarantseva, Galina Y. Kharkevich, Konstantin K. Laktionov, Ekaterina A. Troshina, Galina A. Mel`nichenko
Format: Article
Language:Russian
Published: MONIKI 2022-10-01
Series:Alʹmanah Kliničeskoj Mediciny
Subjects:
hypothyroidism
thyrotoxicosis
immune checkpoint inhibitors
ipilimumab
pembrolizumab
nivolumab
prolgolimab
atezolizumab
durvalumab
avelumab
Online Access:https://almclinmed.ru/jour/article/viewFile/1689/1466

Internet

https://almclinmed.ru/jour/article/viewFile/1689/1466

Similar Items